Geron gets green light for human trial of ES cell-derived product.
Alper
Joe
J
D017321:Clinical Trials, Phase I as Topic / Q000331:legislation & jurisprudence* / Q000379:methods; D017277:Drug Approval; D053595:Embryonic Stem Cells / Q000637:transplantation*; D006801:Humans; D009836:Oligodendroglia / Q000637:transplantation*; D013119:Spinal Cord Injuries / Q000628:therapy*; D033581:Stem Cell Transplantation / Q000379:methods; D014481:United States; D014486:United States Food and Drug Administration